Hormones Balance
Natural health product licensed in Canada
- Licence holder
- Wonder Naturals Inc.
- NPN or DIN-HM
- 80062203
- Status
- Active licence
- Licence date
- 25 June 2015
- Revision date
- 10 February 2025
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Leonurus cardiaca L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les femmes enceintes
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitex agnus-castus Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 800 milligramme | 80 milligramme | Not calculated |
| Actaea racemosa Source : Racine et rhizome | 60 milligramme | Not calculated |
| Leonurus cardiaca Source : Plante entière | 80 milligramme | Not calculated |
| Angelica sinensis Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 milligramme | 50 milligramme | Not calculated |
| Dioscorea villosa Source : Plante entière | 80 milligramme | Not calculated |
| Turnera diffusa Source : Feuille | 80 milligramme | Not calculated |
| Extrait d'isoflavone de soja Source : Extrait d'isoflavone de soja Potency : 40 % Isoflavones | 50 milligramme | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 40 % Isoflavones | 50 milligramme | Not calculated |
| Extrait d'isoflavone de soja Source : Extrait d'isoflavone de soja Potency : 20 % Genistein | Not specified | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 20 % Genistein | Not specified | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Black Cohosh is traditionally used in Herbal Medicine to help relieve the pain associated with menstruation. Used in Herbal Medicine to help relieve premenstrual symptoms and symptoms associated with menopause. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities. Used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flashes. May reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80062203
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.